Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Aims: The effect of the angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear, and data on ARNI treatment in peritoneal dialysis (PD) patients are lacking. The present study was designed to assess...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Med (Lausanne)
Autors principals: Fu, Sha, Xu, Zhenjian, Lin, Baojuan, Chen, Junzhe, Huang, Qiuyan, Xu, Yanchun, Xu, Anping, Chen, Yangxin, Tang, Ying
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255468/
https://ncbi.nlm.nih.gov/pubmed/34235161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.657067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars